Clinical Trials Logo

Filter by:
NCT ID: NCT05647343 Completed - Clinical trials for Adverse Effect of Drugs and Medicaments in Therapeutic Use

Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers

Start date: March 31, 2023
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to assess the safety, tolerability and pharmacokinetics of ATL-001 (ciclopirox olamine) in healthy volunteers

NCT ID: NCT05646771 Completed - Obesity Clinical Trials

Feasibility Study for Collaborate2Lose

Start date: March 13, 2023
Phase: N/A
Study type: Interventional

In this feasibility study, dyads comprising a Veteran with obesity and a cohabiting adult support person will participate in group-based weight management counseling. Counseling will be delivered using an approved virtual technology platform. The curriculum is based on the VA national MOVE! weight management curriculum and involves additional content focusing on couples' communication skills.

NCT ID: NCT05646719 Completed - Presbyopia Clinical Trials

Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia

VEGA-2
Start date: December 22, 2022
Phase: Phase 3
Study type: Interventional

The objectives of this study are: To evaluate the safety and efficacy of Nyxol alone and with adjunctive low dose pilocarpine to improve distance-corrected near visual acuity (DCNVA) in subjects with presbyopia.

NCT ID: NCT05646368 Completed - Bioavailability Clinical Trials

Bioavailability of Select Nutrients From Two Formulations of a Multivitamin/Mineral Supplement

Start date: December 23, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to assess the relative bioavailability of select nutrients from two formulations of a multivitamin/mineral supplement in healthy adults.

NCT ID: NCT05646355 Completed - Colorectal Cancer Clinical Trials

Flatbush FHC Proactive Colorectal Cancer Screening and Navigation

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

The proposed study is a randomized controlled pilot trial designed to assess the effectiveness and acceptability of a proactive screening outreach program on colorectal cancer screening rates on eligible patients in the Flatbush Family Health Center medical practice.

NCT ID: NCT05646069 Completed - Stone, Kidney Clinical Trials

Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

This study is designed to provide an evaluation of currently available disposable flexible ureteroscopes in real-world conditions. Due to high re-processing costs associated with re-usable flexible ureteroscopes, there has been a demand for Urologic device manufacturers to provide single-use flexible ureteroscopes.

NCT ID: NCT05645991 Completed - Aging Clinical Trials

Coconut Sugar Lowers Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

Start date: March 8, 2018
Phase: N/A
Study type: Interventional

The goal of this intervention is to determine the efficacy of coconut sap powder (CSP) to lower arterial stiffness and blood pressure in middle-aged and older adults. Participants will be randomized to the CSP arm or Placebo arm of the study. Primary endpoints include: aortic stiffness assessed by carotid-femoral pulse wave velocity, resting brachial and (non-invasive) carotid blood pressure, and carotid stiffness (e.g. Beta stiffness index, Carotid compliance, Elastic modulus, Distensibility).

NCT ID: NCT05645757 Completed - Bacterial Infection Clinical Trials

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

Start date: April 19, 2023
Phase: Phase 1
Study type: Interventional

This is a Phase 1, single center study to investigate the safety, tolerability, and pharmacokinetics (PK) of three dose-level groups of WCK 6777 (ERT and ZID combination), and two dose-level groups of ERT alone and ZID (WCK 5107) alone in 52 healthy adult male and female subjects aged 18 to 45 years old (both inclusive). Seven treatment cohorts will be evaluated in this study. WCK 6777 will be evaluated in three cohorts - Cohorts 1, 4 and 7- of 8 subjects each (6 study drug combinations and 2 placebos); ERT will be evaluated alone in two cohorts - Cohorts 2 and 5- of 8 subject each (6 ERT and 2 placebos); and ZID will be evaluated in two cohorts, Cohorts 3 and 6, of 6 subjects each (all ZID). The study will be placebo-controlled and double-blinded in all cohorts except Cohorts 3 and 6. No placebo subjects are included in standalone ZID cohorts, since adequate safety data for higher doses of ZID alone in comparison with placebo are available from completed Phase 1 studies of WCK 5107 (ZID) alone and the ZID-only arms of WCK 5222 (cefepime + ZID) studies. The primary objective is to assess the safety and tolerability of three dose-escalating regimens of WCK 6777 ( ERT and ZID combination) and two-dose escalating regimens of standalone ERT or ZID following single daily doses for 7 days in healthy adult subjects.

NCT ID: NCT05645705 Completed - Healthy Clinical Trials

A Two-Week Study of Clinical Safety and Saliva Flow Quantification

Start date: November 28, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the oral tissue tolerance (tissues within the mouth) for irritation caused by added ingredients in mouthwashes. This will be assessed based on oral tissue exams and adverse reactions.

NCT ID: NCT05645432 Completed - Tinnitus Clinical Trials

An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus

Start date: May 10, 2023
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the safety and tolerability of brexanolone in participants with tinnitus following a single 6-hour continuous intravenous (IV) infusion.